Literature DB >> 12044524

Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis.

Anthony J Donaghy1, Patric J D Delhanty, Ken K Ho, Roger Williams, Robert C Baxter.   

Abstract

BACKGROUND/AIMS: The liver is the central organ of the endocrine growth hormone/insulin-like growth factor I (GH/IGF-I) axis and cirrhosis effects a state of acquired GH resistance. Low IGF-I levels are associated with adverse clinical outcomes in cirrhotic patients and may be pathogenic to the complications of cirrhosis. We examined the impact of cirrhosis on hepatic mRNA and serum protein levels for the GH receptor (GHR)/binding protein (GHBP), IGF-I, IGF binding protein (IGFBP)-3 and the acid-labile subunit (ALS).
METHODS: Fifty patients with cirrhosis were studied and liver tissue was obtained from 18. Gene expression was assessed by Northern analysis and serum protein levels by immunoassay.
RESULTS: In cirrhotic liver GHR mRNA and GH binding to microsomal membranes were decreased by 61 and 56%, respectively. Serum GHBP levels were decreased only in severe disease, not correlating with GHR mRNA or GH binding. Hepatic IGF-I and ALS mRNA were significantly decreased by 84 and 68%, respectively, in parallel with serum protein, suggesting transcriptional regulation. Hepatic IGFBP-3 mRNA was unchanged but low serum IGFBP-3 suggested post-transcriptional regulation.
CONCLUSIONS: The decreased mRNA and serum levels for the GH-dependent, hepatocyte produced proteins IGF-I and ALS confirm the importance of GH receptor loss to the GH resistance of cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044524     DOI: 10.1016/s0168-8278(02)00049-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  20 in total

1.  Renal and Gastrointestinal Considerations in Joint Replacement Surgery.

Authors:  Benjamin Voss; Alexander Kurdi; Alexander Skopec; Jasmine Saleh; Mouhanad M El-Othmani; Joseph M Lane; William M Mihalko; Khaled J Saleh
Journal:  J Nat Sci       Date:  2015-02-01

Review 2.  Biochemical investigations in diagnosis and follow up of acromegaly.

Authors:  Katharina Schilbach; Christian J Strasburger; Martin Bidlingmaier
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  GH-binding protein is related to bone mineral density in non-obese androgenized women.

Authors:  M Legan; J Osredkar; S Fisker; A Kocijancic
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

4.  Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis.

Authors:  Yoshiyuki Takahara; Mitsuo Takahashi; Hiroki Wagatsuma; Fumihiko Yokoya; Qing-Wei Zhang; Mutsuyo Yamaguchi; Hiroyuki Aburatani; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

5.  Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.

Authors:  Araní Casillas-Ramírez; Amine Zaouali; Susagna Padrissa-Altés; Ismail Ben Mosbah; Anna Pertosa; Izabel Alfany-Fernández; Maria Bintanel-Morcillo; Carme Xaus; Antoni Rimola; Juan Rodés; Joan Roselló-Catafau; Carmen Peralta
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

6.  Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women.

Authors:  Howard D Strickler; Melissa Fazzari; Andrea Kovacs; Carmen Isasi; Laura A Napolitano; Howard Minkoff; Stephen Gange; Mary Young; Gerald B Sharp; Robert C Kaplan; Mardge Cohen; Marc J Gunter; Tiffany G Harris; Herbert Yu; Ellie Schoenbaum; Alan L Landay; Kathryn Anastos
Journal:  J Infect Dis       Date:  2008-01-15       Impact factor: 5.226

7.  Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis.

Authors:  Carina Gabriela Correa; Bruno da Silveira Colombo; Marcelo Fernando Ronsoni; Pedro Eduardo Soares E Silva; Leonardo Fayad; Telma Erotides Silva; Letícia Muraro Wildner; Maria Luiza Bazzo; Esther Buzaglo Dantas-Correa; Janaína Luz Narciso-Schiavon; Leonardo de Lucca Schiavon
Journal:  World J Hepatol       Date:  2016-06-18

8.  Growth hormone reserve in adult beta thalassemia patients.

Authors:  Guy Vidergor; Ada W Goldfarb; Benjamin Glaser; Rivka Dresner-Pollak
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633

9.  Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.

Authors:  Yun-Lin Wu; Jing Ye; Shu Zhang; Jie Zhong; Rong-Ping Xi
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

10.  A survey of correlation between insulin-like growth factor-I (igf-I) levels and severity of liver cirrhosis.

Authors:  Asghar Khoshnood; Mohsen Nasiri Toosi; Mohammad Jafar Faravash; Alireza Esteghamati; Hosein Froutan; Hadi Ghofrani; Mohammad Kalani; Arash Miroliaee; Ahmad Abdollahi; Andrabi Yasir
Journal:  Hepat Mon       Date:  2013-02-23       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.